BACKGROUND: Pancreaticosplenectomy (PS) is often performed simultaneously with @entity348 ( @entity348 ) to facilitate dissection of the lymph nodes around the splenic artery and splenic hilus. To evaluate the effects of PS on survival, a retrospective study was performed. METHODS: Various clinicopathological factors influencing lymph node @entity3 around the splenic hilus (No. 10) and the splenic artery (No. 11) were studied retrospectively in the upper or middle third of advanced @entity356 @entity1 who underwent @entity348 with PS. The postoperative morbidity, mortality, and survival rate of @entity1 who underwent @entity348 with PS (the @entity348 with PS group) were compared with those of @entity1 who underwent @entity348 alone (the @entity348 -alone group). RESULTS: @entity5 size larger than 41 mm and lymph node No. 2 @entity3 were independently correlated with lymph node No. 10 and No. 11 @entity3 . The mortality rate was similar, but the morbidity rate was significantly higher in the @entity348 with PS group. In the @entity1 with stage I and III, there was no significant difference between the two groups, but in the @entity1 with stage II, the @entity348 -alone group was significantly better than the @entity348 with PS group (P = 0.0400). CONCLUSIONS: Combined PS with @entity348 should never be performed as the standard surgical procedure for every stage of @entity356 , especially stage II.

Total gastrectomy with distal pancreatectomy and splenectomy for advanced XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity5 :: ('MESH:D009369', 'Disease') :: ['Tumor'] @entity348 :: ('MESH:C535338', 'Disease') :: ['total gastrectomy', 'TG'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastasis'] @entity356 :: ('MESH:D013274', 'Disease') :: ['gastric cancer']
@entity356 :: (MESH:D013274,Disease) :: ['gastric cancer']
